Clinical Trials Directory

Trials / Completed

CompletedNCT00488865

RexMedical- Option* Vena Cava Filter IDE Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
100 (actual)
Sponsor
Rex Medical · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study is designed to evaluate the safety and efficacy of the RexMedical Option\* Vena Cava Filter in the treatment of patients who are at increased risk for Pulmonary Embolism and require caval interruption.

Conditions

Interventions

TypeNameDescription
DEVICEIntravascular Filter DeviceVena cava filter which is implanted into the inferior vena cava of patients to prevent recurrent pulmonary embolism. The filter can be utilized as a permanent or retrievable device.

Timeline

Start date
2006-10-01
Primary completion
2008-12-01
Completion
2009-06-01
First posted
2007-06-20
Last updated
2010-08-10
Results posted
2010-08-05

Locations

10 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00488865. Inclusion in this directory is not an endorsement.

RexMedical- Option* Vena Cava Filter IDE Study (NCT00488865) · Clinical Trials Directory